NCT04513145View on ClinicalTrials.gov

Adductor Canal Block

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
OsteoarthritisTotal Knee Replacement
Interventions
DRUG

Ropivacaine injection

Ropivacaine is a local anesthetic that is FDA approved for local anesthetic nerve block.

DRUG

Saline Injection

Saline will be used as a placebo injection

PROCEDURE

Total Knee Arthroplasty

All subjects participating in this study will undergo primary total knee arthroplasty

Trial Locations (1)

28209

OrthoCarolina Research Institute, OrthoCarolina, P.A., Charlotte

All Listed Sponsors
collaborator

Towson Orthopaedic Associates

OTHER

lead

OrthoCarolina Research Institute, Inc.

OTHER